Drug Information

Drug General Information
Drug ID
D01VOU
Former ID
DNC013338
Drug Name
2,2',4,4',6'-pentahydroxychalcone
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528649]
Structure
Download
2D MOL

3D MOL
Formula
C15H12O6
Canonical SMILES
C1=CC(=C(C=C1O)O)C=CC(=O)C2=C(C=C(C=C2O)O)O
InChI
1S/C15H12O6/c16-9-3-1-8(12(19)5-9)2-4-11(18)15-13(20)6-10(17)7-14(15)21/h1-7,16-17,19-21H/b4-2+
InChIKey
MDRJIGPMMMALHB-DUXPYHPUSA-N
PubChem Compound ID
16721049
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [528649]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 528649Bioorg Med Chem. 2007 Mar 15;15(6):2396-402. Epub 2007 Jan 17.Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
Ref 528649Bioorg Med Chem. 2007 Mar 15;15(6):2396-402. Epub 2007 Jan 17.Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.